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Summary Thymus cancer epidemiology has been little investigated, but recent clinical studies have suggested
an association with the Epstein-Barr virus. We studied thymus cancer incidence 1963-83 and mortalitiy
1959-86 in England and Wales, using data from the National Cancer Register and national mortality files.
Mean age-standardised incidence rates of the tumour were 0.72 per million per annum for males and 0.64 for
females; mortality rates were about half of this: 0.43 for males and 0.29 for females. There was no significant
change in rates over time, nor any consistent pattern of risk by region of residence. Birth cohort analysis of
mortality showed in each sex, lowest risk for persons born during the Second World War. The age distribution
of the tumour was unusual: a progressive rise in both incidence and mortality rates occurred in each sex at
ages up to 60-69, at which there was a striking peak, more marked for males and for incidence data, with a
sharp decline thereafter. Immigrants from China and Cyprus had significantly high proportional registration
ratios, but based on small numbers.
The thymus gland plays an important role in the maturation
of immunocompetent T-lymphocyte cells at younger ages. It
enlarges until late puberty and then begins a progressive
morphological and functional involution (Roitt et al., 1985).
Thymus neoplasms are rare, but since the observation in
1901 that they were associated with myasthenia gravis
(Weigart, 1901), there has been interest in their study. Their
aetiology remains obscure, however, and their epidemiology
is unclear because no population-based study has been car-
ried out (Large et al., 1986); most of the available infor-
mation comes from case-reports or relatively small hospital
series (Wilkins et al., 1966; Bernatz et al., 1973; Salyer &
Eggleston, 1976; Maggi et al., 1986). Recently, some clinical
studies have suggested that thymus carcinoma may be
associated with Epstein-Barr virus (EBV) (Leyvraz et al.,
1985; Dimery et al., 1988).
The England and Wales national cancer registry holds an
exceptionally large data set from a catchment population of
about 50 million, which gave an opportunity to investigate
the descriptive epidemiology of these rare tumours and
potentially to give clues for the development of specific
aetiological hypotheses.
Materials and methods
Sources ofdata
Cancer registration has existed at a national level in England
and Wales since 1945, and since 1962 it has had complete
geographical national coverage. Registration is carried out by
regional registries which send data to the national registry at
the Office of Population Censuses and Surveys (OPCS)
(before 1971 the General Register Office) who collate, analyse
and publish the data. Notification of cancers is voluntary and
the methods of data collection are not entirely uniform
among registries; the indications are that completeness is
95% or better in some regions, varies across the country, and
has generally been improving over time (Swerdlow, 1986).
Site of primary malignancy has been coded in the OPCS
files according to the Seventh Revision of the 'International
Classification of Diseases' (ICD), (World Health Organiza-
tion, 1957) for 1959-1967 data, the Eighth Revision (World
Health Organization, 1967) for 1968-1978, and the Ninth
Revision (World Health Organization, 1977) for data from
1979 onwards. Additional codes enable a division by mor-
phological type: using a two-digit OPCS code for 1963-1970
data, the Manual of Tumour Nomenclature and Coding
(MOTNAC) (American Cancer Society, 1968) for 1971-1978
data and the International Classification of Diseases for
Oncology (ICD-O) (World Health Organization, 1976) for
data from 1979 onwards. If no histological information is
available, cancers are registered on the basis of clinical diag-
nosis alone. We extracted from the files of the national
registry data on all registrations incident 1963-83 which
were coded to thymus cancer (ICD7:195.2; ICD8:194.2;
ICD9:164.0). We also extracted, from OPCS mortality files,
unpublished data on mortality from thymus cancer 1959-86.
Mid-year population estimates for each year of the study
period were taken from published sources (General Register
Office, 1959-1970; Office of Population Censuses and
Surveys, 1971-1986).
Methods ofanalysis
Directly age-standardised incidence and mortality rates were
calculated using England and Wales mid-year populations as
denominators and the 'World Standard' population as the
standard (Smith, 1987). To reduce random variation when
examining secular trends, time series data were smoothed by
a moving average of span 5 and weights 1,4,6,4,1/16 (Box &
Jenkins, 1970). The figure derived from this smoothing neces-
sarily does not contain separate data points for the two first
and two last years.
Models based on the assumption that the observed number
of cancer occurrences or cancer deaths arose from a Poisson
distribution were fitted to test the statistical significance of
linear trends in incidence and mortality (Breslow & Day,
1987), using the GLIM (Generalised Linear Interactive
Modelling) (Baker & Nelder, 1978) computer package.
Birth cohort analyses was conducted for mortality but not
for incidence, for which insufficient data were available for
satisfactory analysis. Standardised cohort mortality ratios
(SCMRs) were calculated for each 5-year birth cohort (Case,
1956; Beral, 1974) using, in each sex, the average age-specific
mortality of England and Wales 1960-84 as the standard.
The significance of SCMRs was tested using the significance
factors for the ratio of a Poisson variable to its expectation
given by Bailar and Ederer (1964).
Geographical variation in thymus cancer incidence was
examined by calculating age-standardised registration rates
for hospital regions of residence for 1974-83. This period
was chosen because regional boundaries were changed in
1974. Region of residence was known for all registrations in
the file.
Age-standardised proportional registration ratios (PRRs)
by country of birth were calculated for 1971-83 (PRR of
thymus cancer registrations = 100). Birthplace was known for
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72% of thymus cancer registration and, of these, 96% were
born in the United Kingdom.
The significance of regional rates compared to England
and Wales rates, and of proportional registration ratios by
country of birth, were tested using the tables of Bailar and
Ederer (1964).
Results
A total of 781 cases of thymus cancer were registered in
residents of England and Wales during the 21 year period
from 1963 to 1983, of which 54.3% (424) were in males and
45.7% (357) in females.
The majority of the tumours were thymomas (75.4%)
(Table I); 16.3% were 'thymus carcinomas'-a heterogeneous
group of epithelial neoplasms. Germ cell neoplasms and car-
cinoid tumours were uncommon. The 'other tumours' cate-
gory in the table included sarcomas, liposarcomas, vascular
and granular tumours. The distribution of histologies was
similar in both sexes.
A total of 547 deaths with the underlying cause thymus
cancer occurred during 1959-86, of which 51.6% (282) were
males and 48.4% (265) were females.
Age-standardised incidence (registration) rates are shown
in Figure 1. There was no significant linear trend (males:
observed slope b = -0.007, P>0.10; females: b = -0.013,
P>0.10) nor was there any correlation between male and
female rates in the same years (r = 0.05, P = 0.83).
Similarly, annual age-standardised death rates (Figure 1)
showed no evidence of a trend over time (males: b =
-0.0005, P>0.10; females: b = 0.011; P>0.10), and also no
correlation between male and female death rates for the same
years (r = 0.13, P = 0.52). On examination of mortality by
birth cohort (Figure 2), there was no consistent trend, but in
each sex, persons born during the Second World War had
the lowest risk, although only significantly below 100 for
males (males: SCMR = 15, P<0.05; females: SCMR = 59,
P>0.05). Both values were based on small numbers of
deaths (males = 2; females = 6).
Examining the age distribution of thymus cancer using
aggregated data for the entire study period (Figure 3), both
incidence and mortality in each sex showed a steady increase
in rates up to a peak at ages 60-69, and thereafter a striking
decline in rates, particularly in males and for incidence. The
overall male excess of thymus cancer incidence was
accounted for by the male predominance at the older ages at
which the peak occurred, whereas there was no clear sex
difference at younger age-groups.
Table II shows the geographical distribution of thymus
cancer in England and Wales for 1974-83. Males rates were
higher than female rates for all regions except Wessex and
Oxford; highest rates in males were in East Anglia followed
by the Northern and North East Thames regions. Females
rates were highest in Wessex (the region with the lowest male
rate), followed by Oxford and East Anglia. There was no
correlation between male and female rates for the same
regions (r = 0.25; P = 0.363).
Analysis by country by birth showed significant PRRs for
migrants born in China (PRR = 1,852; P<0.05) and Cyprus
(PRR = 744; P<0.05), but based on very small numbers of
registrations (China = 2; Cyprus = 3).
Table I Thymus cancer: histological distribution, England and Wales,
1963- 1983
Histological type (ICD-O) Number Frequency (%)
Thymomas (M8580) 589 75.4
Thymus carcinoma (M8010-M8043) 127 16.3
Germ cell tumours (M9061-M9083) 15 1.9
Carcinoid tumours (M8240) 2 0.3
Other malignancies 9 1.1
Unknown histology (M8003) 39 5.0
Total 781 100.0
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Figure 1 Secular trends in thymus cancer incidence 1963-83,
and mortality 1959-86, England and Wales (smoothed annual
age-standardised rates). Registration: *, males; *, females. Mor-
tality: +, males; 0, females.
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Figure 2 Birth cohort mortality trends from thymus cancer
among persons born 1900-1960, England and Wales. *, males;
+, females.
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Figure 3 Age distribution of thymus cancer in England and
Wales. Mean annual registration rates 1963-83 and mortality
rates 1959-86. Symbols as Figure 1.
Discussion
Some reservations regarding diagnosis of thymus cancer in
the present data need to be considered. First, thymomas are
considered as malignant because of local invasion or distant
metastases (Rosai, 1985), since the vast majority are mor-
phologically indistinguishable from benign thymomas (Chen,
1984). The distinction between slight invasion and no
invasion is not always clear, however (Jain & Frable, 1974).
Despite these uncertainties, the similarity of the results for
incidence with those for mortality in the present study give
some indication that such diagnostic effects are unlikely to
have affected the quality of the incidence data greatly.
Second, even to establish that a tumour has originated from
the thymus parenchyma is not always an easy task. For
instance the nature of 'granulomatous thymomas' and
'seminomatous thymomas', and their relation to Hodgkin's
disease (Keller & Castleman, 1974) and germ cell tumours
(Levine, 1973) respectively, remains unclear. Since they are a
very small proportion of thymus cancer, however, their mis-
diagnosis would have had a negligible impact in our data.
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TableII Incidenceofthymuscancerbyhospital regionofresidence, EnglandandWales,
1974-83
Males Females
Mean annual Mean annual
No. registration No. registration
Region 1974-83 ratea 1974-83 ratea
Northern 18 1.01 12 0.63
Yorkshire 17 0.83 11 0.49
Trent 15 0.52 14 0.41
East Anglia 14 1.31b 8 0.89
N.W. Thames 16 0.78 11 0.49
N.E. Thames 19 0.89 14 0.62
S.E. Thames 13 0.64 6 0.28
S.W. Thames 9 0.51 7 0.36
Wessex 5 0.28b 15 0.92
Oxford 8 0.60 12 0.91
S. Western 17 0.87 8 0.52
W. Midlands 20 0.64 12 0.44
Mersey 3 0.44 6 0.42
N. Western 15 0.65 12 0.42
Wales 8 0.52 7 0.41
England and Wales 197 0.68 155 0.52
aRate per million directly age-standardised to the 'world' population (Smith, 1987).
bDiffers significantly from England and Wales at P<0.05.
Two additional issues of coding should also be noted.
First, thymomas might fail to be coded as thymus cancer if
the word malignant was arbitrarily omitted on the medical
record. Second, the thymus cancer data exclude thymic lym-
phomas which are allocated in the ICD to lymphoma rather
than thymus cancer. The impact of the first is difficult to
assess. The effect of the second would have been small since
lymphomas arising primarily within the thymus gland are
rare (Keller & Castleman, 1974).
That mortality rates were substantially lower than the
corresponding incidence rates agree with clinical studies
which report a relatively good survival for malignant
thymomas, which form the great majority of thymus cancers
(Batata et al., 1974; Verley & Hollman, 1985; Maggi et al.,
1986). Since classification might be ambiguous, no attempt
was made to analyse the data further by histological
category.
Some clinical reports have suggested an increasing fre-
quency of diagnosis of thymomas in the past decade (Maggi
et al., 1986), but considered that this was probably due to
changes in diagnostic and therapeutic approaches for myas-
thenia gravis rather then a true increase in incidence. Our
population-based study did not show an increase in
incidence. Since diagnostic or therapeutic policy changes in
the recent period may have led to the detection of small
thymomas which would not have been detected in other
ways, and cancer registration has probably improved over
time (Swerdlow, 1986), our data might hide a possible
decrease in incidence over time but are unlikely to corres-
pond to an increase. The lack of correlation between male
and female rates over the regions of England and Wales
suggests that our incidence data have not been grossly
affected by regional incompleteness, which would presumably
have affected both sexes similarly. A lack of secular increase
also corresponds with data from clinical series from Pap-
worth Hospital, Cambridge (Large et al., 1986).
The age distribution of thymus cancer is unusual. Lym-
phoreticular cancers (Greene, 1982), nasopharyngeal cancer
(NPC) (Shanmugaratnam, 1982) and certain other tumours
arising in immunodeficient conditions for which a viral
aetiology has been suspected (Kinlen, 1982), share with
thymus cancer a peak in late middle age, but show some
differences in age distribution, notably in the degree of
decrease at older ages. The distribution of thymus cancer is
particularly similar to that of NPC in high incidence popula-
tions, e.g. Singapore (Shanmugaratnam, 1982), and also of
Creutzfeldt-Jakob disease (P.G. Smith, personal communica-
tion), a neurological disorder suspected of being caused by a
slow viral agent (Roos et al., 1973). In the cancers above,
rates start to rise earlier and steeper than in most malignan-
cies, which may suggest that exposure to carcinogenic agents
begins very early in life. The extraordinary decline of thymus
cancer after late middle age might perhaps indicate cessation
of exposure to an aetiological agent or a decreasing number
of susceptibles in the population, although in part it might be
due to the decline at older ages in thymectomies for myas-
thenia and, hence, less probability of detecting clinically
silent thymomas. Rates start to go down when the thymus
gland is already morphologically involuted but still preserves
some functional activity (Roitt et al., 1985).
The similarities with NPC are particularly interesting
because the nasopharynx and thymus have the same em-
bryological origin from the primitive foregut (Leyvraz et al.,
1985), and because a serological association with EBV has
been well documented for NPC (Shanmugaratnam, 1982)
and has recently been reported for thymus cancer (Leyvraz et
al., 1985; Dimery et al., 1988). Like thymus cancer, NPC also
shows stable time trends (Shanmugaratnam, 1982). The most
outstanding epidemiological feature of NPC, however, is its
very high incidence in southern Chinese, both in and outside
China (Shanmugaratnam, 1982). High rates are found in
other groups in South East Asia, especially Filipinos, and in
Tunisians (Hirayama, 1978). Although our data showed a
significant high risk of thymus cancer among persons born in
China and in Cyprus, no coherent pattern was present.
Thymus cancer data have only been published in Cancer
Incidence in Five Continents (Muir et al., 1987) in the latest
edition, and very small numbers make interpretation difficult:
apart from a very high incidence (1.7 per 100,000 per annum)
in Filipino males in Bay Area, United States, no clear geo-
graphical or ethnic differentials were present.
The low SCMRs observed in both sexes for the generation
born during the Second World War might also relate to a
putative viral aetiology, since a small average family size
characterised that time (Beral et al., 1978) and, hence, per-
haps there was a lesser probability of acquiring infectious
diseases (Reves, 1985). The method used to calculate the
cohort ratios tend to underestimate real decreases, because of
the overlap of adjacent generations (Beral, 1974) and because
of the inevitable use of the overall data to generate the
expected values. It should be noted also that the ratios were
based on small numbers. Since these are recent birth cohorts,
their follow-up as they age will help to clarify this issue.
The role of EBV in human cancers is still controversial
even for NPC, a tumour with which the virus has been
strongly associated (Henderson, 1989). That thymic cells may
contain EBV genome has been postulated in reports of EBV-
induced malignant lymphoproliferative disorders arising in
patients subject to thymic transplantation (Reece et al.,
1981), but the relation, if any, with thymus cancer is unclear.902 I. DOS SANTOS SILVA & A.J. SWERDLOW
So far, EBV has only been shown to be associated with
lymphoepitheliomas (Leyvraz et al., 1985; Dimery et al.,
1985), a small sub-group of thymus carcinoma (Chen, 1984),
and it is not known if there is a link for other morphological
types of thymus cancer.
Further epidemiological investigation of the parallels
between NPC and thymus cancer may be worthwhile to
pursue.
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